GlassScriptPhysician profile
Rachel Koch
NPI 1295431807
$619.35
in general payments reported to CMS, 2019-2025
15 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $47.75 · 2024: $244 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $146.35 | 2024-2025 | Vanflyta |
| Janssen Biotech, INC. | $96.77 | 2023-2025 | Erleada, Imbruvica |
| Astrazeneca Pharmaceuticals LP | $78.39 | 2024-2025 | Calquence, Enhertu |
| Novartis Pharmaceuticals Corporation | $54.33 | 2024 | |
| Phathom Pharmaceuticals, INC. | $40.87 | 2025 | Voquezna |
| Pharmacosmos Therapeutics INC. | $25.54 | 2025 | Monoferric |
| Gilead Sciences, INC. | $24.84 | 2025 | Trodelvy |
| Eisai INC. | $22.29 | 2025 | |
| Genentech USA, INC. | $20.75 | 2023 | Polivy, Lunsumio |
| Glaxosmithkline, LLC. | $19.97 | 2025 | Ojjaara |
| Caris Mpi, INC. | $19.88 | 2025 | Mi Cancer Seek |
| Lilly USA, LLC | $18.29 | 2024 | Jardiance |
| Incyte Corporation | $17.80 | 2024 | Monjuvi, Pemazyre |
| Exelixis INC. | $16.83 | 2025 | Cabometyx |
| Merck Sharp & Dohme LLC | $16.45 | 2024 | Keytruda, Welireg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Koch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.